8-K - Propanc Biopharma, Inc. (0001517681) (Filer)
据 SEC EDGAR 8-K 文件，Propanc Biopharma, Inc.（CIK 0001517681）于 2026-10-29 提交 8-K，报告期为 2026-10-23，涉及 Item 3.01：退市通知或未能满足持续上市规则或标准；上市转移。文件未披露具体交易所、违规细节或后续安排。
报错 · 内容有误？请告诉我们。
Filing Date
2026-10-29
Accepted
2026-10-29 17:00:33
Documents
11
Period of Report
2026-10-23
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 61-03-9882-0780
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)
EIN.: 330662986 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-42806 | Film No.: 261502706
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)
来源：SEC EDGAR 8-K · sec.gov